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O B J E C T I V E S The present study was designed to verify whether the evaluation of femoral plaque
echogenicity might be a useful tool for cardiovascular risk assessment in patients affected by lower
extremity peripheral arterial disease.
B A C KG ROUND Lower extremity peripheral arterial disease is a common manifestation of athero-
sclerosis and is associated with a high risk of developing major cardiovascular events. Vulnerable
atherosclerotic plaque plays a central role in the occurrence of acute ischemic events in different
vascular territories. Furthermore, atherosclerosis is a systemic disease, and the presence of an unstable
atherosclerotic plaque in a certain vascular district, characterized by low echogenicity at B-mode
ultrasound, is associated to a greater prevalence of unstable plaques in other vascular beds.
METHOD S Femoral plaque echogenicity of 246 claudicants with ankle/brachial index 0.90 was
evaluated at B-mode ultrasound by visual analysis and by calculating the grayscale median (GSM) value.
In these patients, the occurrence of myocardial infarction and stroke was prospectively assessed.
R E S U L T S Femoral GSM values and plaque types assessed by visual analysis were highly correlated
by Spearman analysis (rho  0.905, p  0.001). During a median follow-up of 30 months, 32 patients
(13%) had a major cardiovascular event. Compared with patients without events, those who experienced
an event during the follow-up had a lower femoral plaque GSM value (42.9  26.2 vs. 58.8  19.3, p 
0.002) and a higher prevalence of hypoechoic femoral plaque at visual analysis (68.8% vs. 19.6%, p 
0.001). At Cox analysis, femoral GSM showed an inverse relationship with cardiovascular risk, even after
adjustment for possible confounders (hazard ratio: 0.96, 95% conﬁdence interval [CI]: 0.95 to 0.98, p 
0.001). Furthermore, patients with hypoechoic femoral plaques at visual analysis had a 7.24-fold
increased cardiovascular risk compared with patients with hyperechoic plaques after adjustment for
possible confounders (95% CI: 3.23 to 16.22, p  0.001).
CONC L U S I O N S This study demonstrates that the presence of hypoechoic atherosclerotic femoral
plaques is associated with higher cardiovascular risk in lower extremity peripheral arterial disease
patients. (J Am Coll Cardiol Img 2012;5:348–57) © 2012 by the American College of Cardiology
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ulnerable atherosclerotic plaque plays a
central role in the occurrence of acute isch-
emic events in different vascular districts
(1–4). Culprit lesions responsible for acute
oronary syndromes most commonly result from
isruption of vulnerable plaques that are angio-
raphically modest in severity (5– 8). These
upture-prone plaques have certain characteristics,
uch as: a thin cap; a large lipid core composed of
holesterol, lipids, and dead foam cells; and in-
reased inflammatory activity (1,3,4,8,9). Similarly,
istopathological studies demonstrated that certain
orphological features of carotid atheroma, such as
large lipid core separated from the lumen by a thin
r ruptured fibrous cap and the presence of intra-
laque hemorrhage, are associated with increased
troke risk (2). To date, little is known about the
athophysiological implication and the impact on
linical outcome of unstable plaques in the lower
imbs of patients affected by lower extremity periph-
ral arterial disease (LE-PAD), a common mani-
estation of atherosclerosis characterized by a high
isk of developing ischemic vascular events and death
10,11).
Plaque echogenicity, evaluated by B-mode ultra-
ound imaging, has been found to be a simple and
eliable tool in predicting plaque composition.
laques that appear hypoechoic present an inflam-
atory infiltration and are lipid-rich (12,13),
hereas those with high echogenicity have more
brous tissue and calcific components, which make
hem more stable (12,13). It is noteworthy that
therosclerosis is a systemic disease that commonly
nvolves several vascular territories, and recent stud-
es indicate that plaque instability may not be
onfined to a single vascular bed and may involve
ifferent arterial districts simultaneously (14,15).
hus, the early noninvasive visualization of “sensi-
ive” hypoechoic spots in the arterial tree might
ave important clinical implications, potentially
dentifying a subgroup of patients exposed to a
igher cardiovascular risk. Indeed, patients with
nstable femoral or carotid plaques are more likely
o have unstable plaques in the contralateral artery
14,15). In LE-PAD patients, the presence of
ypoechoic femoral plaques is associated with a
reater prevalence of hypoechoic carotid plaques
16). Furthermore, subjects with history of cerebro-
ascular disease and hypoechoic carotid plaques are
t increased risk not only of developing an acute
erebrovascular event, but also an acute coronary
yndrome (17,18). However, to date, little is known
bout the prognostic implications of a hypoechoic hlaque in the lower limbs on cardiovascular events.
his is particularly unfortunate because LE-PAD
as a widespread impact on health beyond the lower
xtremity circulation (10,11). Accordingly, we con-
ucted a prospective study aimed at evaluating the
rognostic impact of femoral plaque echogenicity
n the incidence of myocardial infarction and stroke
n a homogeneous cohort of LE-PAD patients.
M E T H O D S
Patients. A total of 410 consecutive subjects who
ere referred to our vascular laboratory for sus-
ected intermittent claudication were screened for
nrollment in the study. LE-PAD was diagnosed
n the basis of an ankle-brachial index (ABI)0.90
ssociated with 1 or more stenoses of lower extrem-
ty arteries at B-mode ultrasound. According to
hese criteria, 43 subjects were classified as not
aving LE-PAD. In addition, 14 claudi-
ants with ABI 1.4 were excluded be-
ause these values may be falsely elevated
ue to severe arterial calcification, and 11
atients were excluded because they were
ffected by critical limb ischemia. Thus,
42 patients affected by intermittent clau-
ication were initially selected. Of these,
4 were excluded for 1 of the following
xclusion criteria: acute coronary syn-
romes, cerebrovascular events, or revas-
ularization procedures during the previ-
us 6 months; abnormal myocardial
schemia stress test at enrollment; signifi-
ant renal, hepatic, or inflammatory dis-
ase; decompensated heart failure; or ma-
ignant neoplasia. Therefore, 318 patients affected
y LE-PAD at stage II of Fontaine classification
ere potentially suitable to be enrolled in the study.
o be included, claudicants should have at least an
therosclerotic plaque in 1 or both femoral arterial
istricts within 4 cm proximal and 1 cm distal to the
emoral bifurcation. Thus, 72 patients were ex-
luded for 1 of the following reasons: absence of
emoral plaque (n  3); presence of plaque in
emoral arteries 1.3 mm because such plaque
ould not be clearly separated from diffused thick-
ned intima-media complex (n  4) (19); presence
f calcified femoral plaque with an acoustic shadow
ecause it was technically not reliable to determine
ts echogenicity (n  34); previous femoral revas-
ularization procedure (n  20), under the assump-
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350examined (n 11). Therefore, the study was finally
conducted in 246 LE-PAD patients affected by
intermittent claudication. All the women were
post-menopausal, and none was receiving hormone
replacement therapy. Participants gave written in-
formed consent to the study, which was approved
by our institutional ethics committee.
In each patient, clinical history and risk factors
were assessed. Smokers included current and former
smokers. Hypertension was diagnosed if systolic
arterial pressure exceeded 140 mm Hg and/or
diastolic arterial pressure exceeded 90 mm Hg on
repeated measurements, or if the patient used anti-
hypertensive drugs because of a history of arterial
hypertension. Hypercholesterolemia was diagnosed
if fasting plasma low-density lipoprotein cholesterol
exceeded 130 mg/dl, or if the patient used lipid-
lowering drugs because of a history of hypercholes-
terolemia (20). Diabetes mellitus was diagnosed if
plasma fasting glucose exceeded 126 mg/dl or if the
patient used hypoglycemic agents. Body mass index
was calculated as body mass (kg) divided by height
(m) squared.
All patients were treated according to the most
recent guidelines (11), and response to therapy
(including side effects) was evaluated at regular
clinical evaluations during follow-up and, when
necessary, therapeutic adjustments were performed.
ABI was measured after participants rested su-
pine for 5 min. The systolic blood pressure in both
brachial arteries and the ankle systolic blood pres-
sure in the right and left posterior tibial and dorsalis
pedis arteries were measured using a Doppler probe.
The ABI for each leg was then determined using
the higher of the 2 readings from either the poste-
rior tibial or dorsalis pedis arteries and the higher of
the 2 brachial readings. The lower ABI of the 2 legs
was used for diagnostic purposes.
Deﬁnition of femoral plaque type by visual analysis.
All patients underwent ultrasound examinations of
the lower limbs with an ImagePoint Hx Ultrasound
System (Hewlett-Packard, Andover, Massachu-
setts) with a 7.5-MHz linear array transducer.
Several variables on the scanner were standardized
to optimize image quality and to avoid variability in
B-mode image acquisition between subjects. The
aim was to allow acquisition of maximal data with
the least image modification by the scanner or
operator. Briefly, dynamic range was set at 55 dB,
persistence at 2, gain at 55, and depth gain com-
pensation was maintained as flat. B-mode-images
of femoral arteries were kept in longitudinal and
transverse sections in order to obtain full visualiza-tion of the femoral district and extent of the lesions.
The best longitudinal section with full display of
the plaque and adventitia was stored and used for
visual and computer-assisted analysis. In case both
femoral districts presented an atherosclerotic plaque
or there was more than a plaque in the same femoral
district, only the 1 with lower echogenicity was
considered for the analyses. Femoral plaques were
classified according to a modified version of the
classification proposed by Gray-Weale et al. (21,22)
and graded as: type 1  echolucent; type 2 
redominantly echolucent; type 3  predominantly
chogenic; or type 4  echogenic. The study
opulation was then categorized into 2 groups
ccording to the femoral plaque echogenicity. Pa-
ients with types 1 or 2 plaque were considered to
ave hypoechoic plaque, whereas patients with
ypes 3 or 4 plaque were considered to have hyper-
choic plaque. A single well-trained investigator
V.S.), unaware of the patient’s clinical status,
erformed all the ultrasound examinations, stored
he best longitudinal images of the femoral plaque,
nd evaluated plaque echogenicity at visual analysis.
Femoral grayscale median analysis. The grayscale
edian (GSM) analysis was performed by a single
nvestigator (G.S.), unaware of the visual analysis,
ho analyzed echogenicity in all the plaque images
ith the Image J software (National Institutes of
ealth, Bethesda, Maryland). GSM of the fre-
uency distribution of gray values of the pixels
ithin the plaque served as a measure of echoge-
icity. Standardization was obtained as previously
eported (23). Subsequently, the plaque was out-
ined and its overall brightness evaluated by means
f GSM grayscale range of 0 (black) to 255 (white).
he GSM value of the plaque was adjusted linearly
o that the median value of blood was 0 and that of
dventitia was 190.
Measurement of femoral plaque thickness and stenosis.
The maximum thickness and the percentage steno-
sis of the femoral plaque considered for visual and
GSM analyses were measured from a longitudinal
view of the femoral district by the investigator who
performed the visual analysis (V.S.). Femoral
plaque thickness was considered as the maximum
distance from the leading edge of the lumen-intima
interface to the leading edge of the media-
adventitia interface. To evaluate the femoral per-
centage stenosis, the reference (normal) lumen di-
ameter of the artery and the residual lumen
diameter at the point of maximum stenosis were
obtained using the cursors on the ultrasound image.
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351the residual with the reference lumen diameter. In
obtaining these measurements, the operator took
care to optimize the view of the artery and the
stenosis and used the outline of the color area and
the background B-mode image to determine where
best to place the cursors for diameter measure-
ments. Figure 1 reports representative ultrasound
images of 2 femoral atherosclerotic plaques ob-
tained in our population.
Assessment of carotid intima-media thickness. Ca-
otid ultrasound examination was performed at
aseline in all patients enrolled in the study using
he ultrasound system previously described. Ac-
ording to the Mannheim Consensus (24), carotid
ntima-media thickness (IMT) was evaluated in a
0-mm long segment just proximal to the carotid
ulb using scans of the common carotid artery.
MT was measured as the distance from the leading
dge of the lumen-intima interface to the leading
dge of the media-adventitia interface of the far
all (24). Maximum carotid IMT, defined as the
reatest axial thickness obtained in both carotid
rteries, was considered for each patient.
Assessment of cardiovascular events. Patients were
contacted for follow-up at 3-month intervals. The
occurrence of fatal and nonfatal acute myocardial
infarction and ischemic stroke was prospectively
assessed. The minimum follow-up period was 6
Figure 1. Femoral Plaques
Representative ultrasound images of 2 atherosclerotic femoral plaq
tics. GSM  grayscale median.months. Medical records and death certificates of
all patients who had an event were obtained and
validated by a physician unaware of the echogenicity
of femoral plaques (G.G.). For patients who had
more than 1 event, only the first event was consid-
ered for the analysis.
Statistical analysis. Statistical analyses were per-
formed using SPSS version 12.0 (SPSS, Inc., Chi-
cago, Illinois) and Stata version 10.0 (Stata Corp.,
College Station, Texas). Variables were expressed as
absolute number and percentage, mean  SD, or
median (interquartile range [IQR]). Comparisons
were made by chi-square test, t test for unpaired
samples, or Mann-Whitney U test, as appropriate.
To assess the intraoperator reproducibility, 40
plaques were re-evaluated by the same operator
blinded to the previous results. Intraoperator agree-
ment was assessed by kappa statistic for visual
analysis and by intraclass correlation coefficient
(ICC) with 95% confidence interval (CI) for GSM
analysis. The ICC chosen was of single measures
and absolute agreement with random effect. The
agreement between 2 repeated evaluations of the
plaques was excellent for both visual (kappa 0.85)
and GSM analyses (ICC  0.91, 95% CI: 0.84 to
0.95).
The relationship between plaque type evaluated
by visual analysis and GSM value was assessed by
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352Spearman analysis. Cox proportional hazard analy-
ses were performed to verify if femoral GSM
(continuous variable) and the presence of hy-
poechoic femoral plaques at visual analysis (categor-
ical variable) were associated with the occurrence of
future myocardial infarction or stroke. The follow-
ing covariates, potential contributors of cardiovas-
cular risk in LE-PAD patients, were included in the
adjusted model: age; sex; previous myocardial in-
farction or stroke; ABI; maximum carotid IMT;
and femoral plaque thickness.
To identify the GSM threshold level that pro-
vided the best cutoff for outcome prediction, we
chose the value in which the sum of specificity and
sensitivity was the highest. This value was obtained
by receiver-operating characteristic (ROC) curve
analysis (25). To test the robustness of the results,
we used the bootstrap approach (26). After ran-
domly sampling the study population, drawn with a
replacement 200 times, the mean and the 95% CI of
the 200 bootstrapped cutoff estimates were calcu-
lated. This mean value was used as the best cutoff.
Cumulative event rates in patients with GSM 
cutoff obtained by bootstrap approach versus pa-
tients with higher GSM values were estimated by
Kaplan-Meier curves and probability values by log-
rank test. Similarly, cumulative event rates were
calculated in patients with hypoechoic versus hy-
perechoic femoral plaques at visual analysis.
The C statistic was used to assess the ability to
classify risk (27). Comparison between C statistics
was made by the pairwise comparison of ROC
curves.
All statistical tests were 2-sided. For all tests, a p
value 0.05 was considered statistically significant.
R E S U L T S
Patient characteristics. Table 1 shows the baseline
haracteristics of the study population. Importantly,
he LE-PAD population enrolled in this study
xhibited a high prevalence of classic cardiovascular
isk factors and a high cardiovascular comorbidity.
Table 2 reports baseline characteristics of the
tudy population according to the presence of hy-
oechoic or hyperechoic femoral plaques at visual
nalysis. Notably, patients with hypoechoic plaques
n  64) showed a higher prevalence of previous
yocardial infarction and tended to be younger
han subjects with hyperechoic plaques (n  182).
onversely, no differences between the 2 groups
ere observed with respect to ABI, prevalence of
ther classic cardiovascular risk factors, cardiovas-ular medications, maximum carotid IMT, and
emoral plaque severity.
Table 3 shows the use of cardiovascular medica-
ions after 6 months of follow-up in all the study
opulation and after categorization in those with
ypoechoic versus hyperechoic femoral plaques.
mportantly, no difference between the groups
ould be observed at this time point.
Femoral plaque characteristics and outcome. During
a median follow-up of 30.0 (IQR: 13.0 to 41.0)
Table 1. Baseline Characteristics of the Study Population
(n  246)
n
Mean  SD, %
or Median (IQR)





SBP, mm Hg 137.3 25.0
DBP, mm Hg 76.6 14.7
Hypercholesterolemia 194 78.9%
Total cholesterol, mg/dl 193.6 43.7
LDL, mg/dl 117.1 40.3
HDL, mg/dl 49.9 12.8
Diabetes mellitus 98 39.8%
Blood glucose, mg/dl 116.3 42.7
BMI, kg/m2 26.5 3.5
Comorbidity
CAD 168 68.3%
Previous MI 118 48.0%







Maximum IMT, mm 1.23 0.16
LE-PAD severity
Fontaine stage IIA 136 55.3%
Fontaine stage IIB 110 44.7%
ABI 0.67 0.19
Femoral plaque features
Thickness, mm 2.91 0.83
Percentage stenosis 43.5 13.1
Hypoechoic plaque 64 26.0%
GSM 61.4 (42.0–74.9)
ABI  ankle-brachial index; ACE  angiotensin-converting enzyme; BMI 
body mass index; CAD  coronary artery disease; DBP  diastolic blood
pressure; GSM  grayscale median; HDL  high-density lipoprotein; IMT 
intima-media thickness; IQR  interquartile range; LDL  low-density lipo-
protein; LE-PAD  lower extremity-peripheral arterial disease; MI  myocar-
dial infarction; SBP  systolic blood pressure.months, 32 of the 246 patients (13%) had an event:
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 4 , 2 0 1 2
A P R I L 2 0 1 2 : 3 4 8 – 5 7
Schiano et al.
Femoral Plaque Echogenicity and Outcome in LE-PAD
35326 had a myocardial infarction and 6 had a stroke.
Compared with patients without events, those who
experienced an event during the follow-up had a
lower femoral plaque GSM value (42.9  26.2 vs.
58.8 19.3, p 0.002), and a higher prevalence of
hypoechoic femoral plaque at visual analysis (68.8%
vs. 19.6%, p  0.001).
Considered as a continuous variable, femoral
GSM was inversely associated with cardiovascular
risk (Table 4). This association remained statisti-
cally significant after adjustment for potential con-
founders (Table 4).
Spearman analysis showed that femoral GSM value
and plaque type assessed by visual analysis were highly
correlated (rho 0.905, p  0.001) (Fig. 2). Consis-
tently, Cox analyses revealed that the presence of
hypoechoic femoral plaques at visual analysis was
associated with an increased risk of developing myo-
cardial infarction or stroke, even after adjustment for
possible confounding factors (Table 4).
Figure 3 displays the ROC curve for GSM in
relation to the occurrence of myocardial infarction
or stroke. The GSM cutoff value that provided the
maximum sum of the specificity and sensitivity in
predicting the outcome was 30.2. The C statistic
(area under the curve) for this GSM value was 0.68
(95% CI: 0.63 to 0.73, p  0.001). The boot-
strapped cutoff value estimate for GSM was 31.4
(95% CI: 25.2 to 35.7).
Kaplan-Meier survival curves showed that the
incidence of myocardial infarction or stroke during
follow-up was significantly higher in patients with
femoral GSM value 31.4 versus those with
greater GSM value (Fig. 4). Similar results were
observed when patients were categorized according
to visual analysis (Fig. 4). Notably, at Cox analysis
adjusted for potential confounders, patients with
GSM 31.4 presented a 5.74-fold increased risk of
developing a cardiovascular event compared with
patients with higher GSM value (Table 4).
The C statistic for the risk prediction model
incorporating age, sex, smoking, hypertension, hy-
percholesterolemia, diabetes, body mass index, pre-
vious myocardial infarction or stroke, ABI, carotid
IMT, and femoral plaque thickness and percentage
stenosis was 0.71 (95% CI: 0.65 to 0.76), similar to
that of GSM alone (0.68, 95% CI: 0.63 to 0.73,
p  0.624). Notably, it significantly increased to
0.78 (95% CI: 0.72 to 0.83, p  0.048) when the
model incorporated also GSM, suggesting a signif-
icant contribution of femoral plaque echogenicity
evaluation on cardiovascular risk assessment.D I S C U S S I O N
Our prospective study demonstrates that LE-PAD
patients with a hypoechoic plaque in the femoral
arteries are exposed to a significantly higher risk of
developing myocardial infarction or stroke com-
Table 2. Characteristics of LE-PAD Patients According to the Pr





Age, yrs 63.6 9.2 66.1
Men 54 (84.4) 152 (8
Risk factors
Smoking 58 (90.6) 176 (9
Hypertension 50 (78.1) 148 (8
SBP, mm Hg 134.7 27.9 138.2
DBP, mm Hg 74.0 11.1 77.5
Hypercholesterolemia 52 (81.3) 142 (7
Total cholesterol, mg/dl 189.8 46.7 194.8
LDL, mg/dl 112.2 44.6 118.6
HDL, mg/dl 47.6 11.4 50.6
Diabetes mellitus 24 (37.5) 74 (4
Blood glucose, mg/dl 119.7 51.8 115.0
BMI, kg/m2 26.3 3.7 26.5
Comorbidity
CAD 46 (71.9) 122 (6
Previous MI 38 (59.4) 80 (4
Previous stroke 4 (6.2) 8 (4
Medications
Antiplatelets 56 (87.5) 166 (9
Beta-blockers 20 (31.3) 56 (3
ACE-inhibitors 44 (68.8) 116 (6
Statins 37 (57.8) 117 (6
Carotid IMT
Maximum IMT, mm 1.25 0.15 1.22
LE-PAD severity
ABI 0.67 0.17 0.67
Femoral plaque severity
Thickness, mm 2.98 0.81 2.87
Percentage stenosis 44.7 14.9 43.0
Values are mean  SD or n (%).
Abbreviations as in Table 1.







Antiplatelets 242 (98.4) 64 (100.0) 178 (9
Beta-blockers 86 (35.0) 24 (37.5) 62 (3
ACE inhibitors 172 (69.9) 44 (68.8) 128 (7
Statins 183 (74.4) 48 (75.0) 135 (7

































rsus hyperechoic femoralAbbreviation as in Table 1.
as in Figur
CI  conﬁdence interval;
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354pared with those with a hyperechoic femoral
plaque. Similar findings were obtained with both
computer-assisted and visual analyses of plaque
echogenicity. Notably, these results remained unal-
tered after accounting for factors known to have
important impacts on LE-PAD patients’ outcome,
including age, sex, previous cardiovascular events,
and ABI.
Acute ischemic events are more closely related to
the histopathological characteristics of atheroscle-
rotic plaques than to the number of plaques or the
degree of vascular stenosis (2,5–8,28,29). In this
regard, the PROSPECT (Providing Regional Ob-
servations to Study Predictors of Events in the
Coronary Tree) trial (8) has recently shown that
lesions responsible for recurrent cardiac ischemic
events are frequently angiographically mild, most
are thin-cap fibroatheromas, or are characterized by
a large plaque burden, a small luminal area, or some
combination of these characteristics, as determined
by grayscale and radiofrequency intravascular ultra-
sonography. Although histology is the gold stan-
dard to determine plaque structures, it requires
invasive arterial explants. In contrast, high-resolution
B-mode ultrasound is a simple, low cost, and
reliable noninvasive method for the evaluation of





Type 2 Type 4Type 3
Correlation Between Visual and Computer-Assisted
ity Analyses
between visual classiﬁcation of plaque echogenicity (4 types)
alue (presented as median and interquartile range). Abbreviation
djusted HR of Developing MI or Stroke in LE-PAD Patients (Cox A
Femoral GSM* Hypoechoic
HR 95% CI p Value HR 95%
0.96 0.95–0.98 0.001 7.15 3.38–
0.96 0.95–0.98 0.001 7.24 3.23–
R is shown for an increase of 1 U. †Multivariate Cox analyses adjusted for age, s
HR  hazard ratio; other abbreviations as in Table 1.e 1.known to be related to the histological characteris-
tics of the atherosclerotic lesion (13,21). Indeed,
plaques that appear hypoechoic on B-mode ultra-
sound have a pronounced inflammatory infiltration,
a high lipid content, and are more prone to rupture
(12,30,31), whereas hyperechoic plaques consist
mainly of fibrous tissue, collagen, and calcium,
which make them more stable (12,13).
Notably, plaque instability has been considered a
multivessel phenomenon, and thus, vulnerable
plaques may occur simultaneously in different parts
of the arterial tree in the same individual. Indeed,
patients with an acute coronary syndrome show the
concomitant presence of multiple unstable plaques
in the coronary tree and in the carotid district
(32–34). Furthermore, although it is known that
patients with history of cerebrovascular events and
hypoechoic, probably unstable, carotid plaques are
at increased risk of future ischemic events in the
cerebral and coronary districts (17,18,29), little is
known about the predictive role of femoral plaques
echogenicity in LE-PAD.
Although LE-PAD is a common manifestation
of atherosclerosis and is associated to a high inci-
dence of major cardiovascular events (10,11), this
increased risk appears to be poorly related to classic
risk factors (10,35). In this regard, other parameters
have been described as independent risk predictors
in LE-PAD, such as the disease severity evaluated
by ABI, a worse endothelial function, and a more
pronounced inflammatory status (11,36–42). The
present study suggests that the presence of hy-
poechoic femoral plaques might be considered a
new marker of cardiovascular risk in LE-PAD.
Indeed, the identification of a vulnerable site (hy-
poechoic spot) in femoral arteries might identify
patients at increased risk of “remote” coronary or
carotid adverse events, suggesting that the presence
of an unstable plaque in a certain artery might be
associated with the presence of unstable plaques in
other districts. At this regard, autoptic and echo-
graphic studies show that atherosclerosis develops
slowly in the femoral artery compared with coronary
lysis)
oral Plaque Femoral GSM <31.4
p Value HR 95% CI p Value
1 0.001 7.10 3.53–14.29 0.001
2 0.001 5.74 2.64–12.47 0.001




















*For continuous variable, H ex, pand carotid arteries (43,44), suggesting that the
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355presence of femoral plaques might indicate a gen-
eralized susceptibility to atherosclerosis and vulner-
ability to coronary events.
These findings are clinically relevant, because
nearly all LE-PAD patients present in the femoral
bifurcation an atherosclerotic plaque, whose echo-














Figure 3. GSM ROC Curve
Receiver-operating characteristic (ROC) curve illustrating the sen-
sitivity and speciﬁcity of GSM in predicting the occurrence of
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Figure 4. Patients’ Outcome According to Femoral Plaque Echo
Kaplan-Meier analysis of event-free survival curves in patients with
(A) Analysis considering patients with GSM 31.4 (hypoechoic plaque
sis considering patients with hypoechoic (types 1  2) versus patients
events/number of patients in each subgroup is reported in parentheses. Asound during the routine diagnostic evaluation.
Although the echogenicity evaluation of the major
number of plaques might represent the optimal
strategy to estimate arterial health, systematic eval-
uation of all arterial plaques of the lower limbs
might be extremely difficult and time-consuming.
In contrast, the femoral district next to the bifur-
cation is the most commonly involved in lower
limbs arterial atherosclerosis, and it can be easily
and reliably visualized in the vast majority of pa-
tients undergoing lower limbs ultrasound evalua-
tion. Indeed, in the present study, femoral plaque
echogenicity evaluation was applicable in almost
80% of LE-PAD at stage II of Fontaine classifica-
tion.
Our results might inspire future studies aimed at
verifying the current hypothesis that plaque vulner-
ability is a systemic phenomenon. Indeed, a large
body of data suggest that plaque vulnerability is
only partly determined by local factors, because
systemic factors such as infection, inflammation,
autoimmunity, or specific genes may also be in-
volved (45–48). In particular, high systemic levels
of inflammatory markers are associated with the
presence of vulnerable plaques in multiple vascular
districts (32,49). In this regard, in LE-PAD pa-
tients, the vascular bed of lower limbs provides a
large surface that, in the presence of vulnerable
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oechoic (green line) and hyperechoic (red line) femoral plaques.
sus patients with higher GSM value (hyperechoic plaque). (B) Analy-
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356matory molecules that might contribute to vascular
impairment at distant sites.
Study limitations. Our results refer to a restricted
category of patients with significant and severe
atherosclerotic disease of the lower limbs, ABI
0.90, and high prevalence of cardiovascular risk
factors and cardiovascular comorbidity. In particu-
lar, we enrolled only patients with LE-PAD at
stage II of Fontaine classification (intermittent
claudication). Therefore, our results cannot be ex-
tended to the general population or to patients
affected by critical limb ischemia (stages III and IV
of Fontaine classification), and, especially, to pa-
tients with asymptomatic disease (stage I of Fon-
taine classification), who represent the majority of
the LE-PAD population and whose cardiovascular
risk is not much lower than that of claudicants (50).
Furthermore, it is important to emphasize that
about 22% of the LE-PAD patients at stage II of







of a chronic systemlimitations regarding femoral plaque echogenicity
evaluation.
C O N C L U S I O N S
The presence of hypoechoic atherosclerotic plaques
in the femoral arteries entails an increased risk of
future myocardial infarction and ischemic stroke in
LE-PAD. This information may be obtained by
computer-assisted or visual analyses. These findings
are clinically relevant, because the simple, inexpen-
sive, and noninvasive visual evaluation of femoral
plaque echogenicity by B-mode ultrasound might
help to identify vulnerable LE-PAD patients
potentially exposed to higher cardiovascular risk.
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